Vimarsana
Biggest News Aggregation in the World

Page 3 - Fda Approved News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approved. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approved Today - Breaking & Trending Today

North Carolina: Alzheimer clinical trial - Vimarsana News

North Carolina: Alzheimer clinical trial

Two North Carolina universities are conducting clinical trials involving a Food and Drug Administration-approved drug for Alzheimer’s.

Source: wyff4.com
North Carolina: Wake Forest and Duke University holding clinical trails for an FDA-approved drug to prevent Alzheimer's - Vimarsana News

North Carolina: Wake Forest and Duke University holding clinical trails for an FDA-approved drug to prevent Alzheimer's

Both Wake Forest and Duke University are holding the trails.

Source: wxii12.com
The first chikungunya vaccine could be a game changer in global health - Vimarsana News

The first chikungunya vaccine could be a game changer in global health

The FDA's approval of a chikungunya vaccine brings hope to regions facing the highest risk of the mosquito-borne virus that has affected over 110 countries.

AMA urges insurance coverage parity for emerging obesity treatment options - Vimarsana News

AMA urges insurance coverage parity for emerging obesity treatment options

As a new generation of weight-loss medications has created additional options to treat obesity, insurance coverage barriers limit broad accessibility of these medications. In response, physicians and medical students voted to adopt policy for the American Medical Association (AMA) supporting health insurance coverage parity for evidence-based treatment of obesity, including FDA-approved medications without exclusions or additional carve-outs. The AMA regards obesity as a disease that pose...

FDA authorizes use of diabetes drug tirzepatide for weight loss - Vimarsana News

FDA authorizes use of diabetes drug tirzepatide for weight loss

The Food and Drug Administration has authorized Zepbound, which is manufactured by Eli Lilly, approval to be prescribed as a weight-management treatment, paving the way for more people to gain access to the medication.

Source: yahoo.com